Join Boston Biotech Clinical Research in Houston, April 15, at the premier professional development and networking event for the clinical research profession, the ACRP 2012 Global Conference & Exhibition.

SPEAKER: Candida Fratazzi, MD, President, BBCR, LLC

SESSION #S023: The Rising Interest in the Rare Disease Model could have a critically important role into Biomarker's implementation for Stratified Medicine.

ABOUT: Innovation in drug development has driven the rising interest in a niche market that strictly connects to stratified medicine. Biomarkers are key in identifying patients who are more likely to benefit in response to a given therapy, and are anticipated to affect significantly both the development of new drugs and diagnostics and clinical practice. More than 25 years of orphan drug regulations have proven the strength of the rare diseases model, and the possibility of providing a critically important window into drug development that can be of benefit across the full range of biomarkers’ implementation in stratified medicine. Tools that can help new biomarkers’ identification are available and need to be discussed.